Document is current

Article History

Received: 19 June 2017

Accepted: 22 January 2018

First Online: 20 February 2018

Authors’ information

: EC: MSc, PhD with background in neuropsychology and neuroimaging.ES: PT with background in clinical physiotherapy and neuroimaging.MF: MD, FEAN with background in clinical neurology and neuroimaging.FA: MD, PhD with background in clinical neurology and neuroimaging.All authors have specific training and expertise in MRI and neurodegenerative diseases.

: Not applicable.

: Not applicable.

: EC has received research support from the Italian Ministry of Health; MF is Editor-in-Chief ofJournal of Neurology; serves on a scientific advisory board for Teva Pharmaceutical Industries; has received compensation for consulting services and/or speaking activities from Bayer Schering Pharma, Biogen Idec, EXCEMED, Merck Serono, and Teva Pharmaceutical Industries; and receives research support from Bayer Schering Pharma, Biogen Idec, Merck Serono, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, Cure PSP, Alzheimer’s and Drug Discovery Foundation, and the Jacques and Gloria Gossweiler Foundation (Switzerland); FA is a Section Editor forNeuroImage:Clinical; has received speaker honoraria from EXCEMED—Excellence in Medical Education and Biogen Idec; and receives research supports from the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA), and the European Research Council. ES declares that she has no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.